Healthcare and Life Sciences

Our technology applications extend beyond public health to provide a broad range of actionable insights.

RIWI technology was first developed by a faculty member at the Dalla Lana School of Public Health at the University of Toronto to inform the Ontario government on how people across the world were protecting themselves against the H1N1 virus, and the extent to which they trusted government public health communications.

Now, RIWI’s data solutions extend across a spectrum of applications in public and private healthcare and life sciences. We ask healthcare consumers and healthcare professionals about their perspectives on changing products/services to improve health system access, pharmaceutical products and digital therapeutics, healthcare delivery and human rights. RIWI capabilities can also be leveraged to enhance clinical trial recruitment efforts, including the testing of clinical trial concepts and messaging, the evaluation of trial designs using RIWI data points and broadening the impact and reach of clinical studies to optimize resource utilization and efficiency relating to clinical trial recruitment processes.

RIWI is proud to help tackle issues aimed at improving health and well-being across geographies. This is referenced by work on vaccine hesitancy with the Global Health Crisis Coordination Center (GHC3)/Center for Disease Control (CDC), stigma surrounding vulnerable or under-represented groups such as drug users with Elevyst, and monitoring of public health security and testing public reaction to infectious diseases on a regional, national or global scale with the Fields Institute. Other clients include the World Food Programme, the International Displacement Monitoring Center and the Bill and Melinda Gates Foundation.

How
We
Help

Tackle issues that improve health, well-being, treatment and drug formulation and delivery, as well as clinical trial recruitment using secure and adaptable data collection methodology:

Deploy custom surveys for continuous trend tracking, measurement and prediction of increasingly important topics that are often neglected due to their sensitive nature. By providing a secure environment for individuals to express their opinions on sensitive or stigmatized topics, RIWI is able to collect data points on issues typically impacted by self-reporting and observational biases in traditional surveys, critical for drawing conclusions from healthcare and life sciences research.
Manage large scale content and concept testing through randomized control trials that overcome geographical restrictions, facilitating feedback from the hardest-to-reach populations. Capture your target audience’s views and perceptions on pharmaceutical products, digital therapeutics or healthcare delivery, by evaluating how messages, concepts, ads, information, and even product labels resonate with the intended population, patient or user group.
Increase awareness of your brand and educate potential users, by showcasing and redirecting individuals to informational web pages, platforms or app stores. Target specialized groups based on their web activity or reach larger audiences with campaigns relevant to their healthcare topics of interest.
Rapidly assess critical and evolving situations such as infectious disease outbreaks, pandemic responses including lockdowns as well as the reputational impact of black-box warnings issued by the FDA . Identify solutions to address HCP and patient sentiment around event-driven matters such as pharma product/device recalls. Inform effective responses to legal situations including anti-competitive behavior relating to generic drugs, kickback lawsuits, antitrust lawsuits, opioid-related lawsuits, and other high-profile events that attract local or global public and media attention.
Recruit and screen participants for clinical trials, leveraging geo-targeting capabilities to meet necessary demographic parameters. Diversify your recruitment efforts by reaching internet users who are not typically captured via traditional recruitment efforts. Harness RIWI’s specialized methodologies to mitigate the risk of trial delays arising from retention issues, by using proactive real-time recruitment methods.

Anonymous Data

Collect sentiment data on sensitive topics. No personally identifiable data are requested, scraped, or otherwise ingested.

Cutting-Edge Methodology

Compliment your existing data points or uncover alternative perspectives using cutting-edge methodology.

Real-Time Dashboards

Collect data 24/7 and access in-the-moment insights with RIWI real-time dashboards.

Worldwide Reach

Uncover geo-specific sentiment by targeting users at the country, regional or city level.

Examples of questions we help answer:

What is the potential demand for a Pharma product/Healthcare service/Wellness app? Will patients/consumers use the drug/device/app? Can the healthcare product/service be successful in a specific market?
How do patients feel about a specific condition/drug/treatment/hospital/brand/product/service/health system/healthcare policy or delivery approach?
Is there a need to change a product, process, or how it is communicated at present?

Are people aware of a specific healthcare service or product? How do they feel about using it?
What do people currently believe/feel/know about certain conditions, treatments, treatment facilities, or policies?
Can I reach and engage more patients to use or learn about a nominated healthcare issue/product/service, or change their behaviour relating to it?
How do healthcare stakeholders view different topics or issues?

Related Research

bottles of covid-19 vaccines

RIWI’s RDIT Tracks Vaccination Rates in Real Time in the U.S.

Busy street in Bangladesh

iMMAP: COVID in Syria and Bangladesh, Colombia

RIWI Powered Report Finds Stigma Toward People who use Drugs, Suffer From Addiction, and are in Recovery

Bryan Smith
CEO, THINKDATA

CUSTOMER STORY
Forward-looking data is the only way to accurately see how the pandemic is spreading. Working with RIWI to design a custom survey instrument that pulled in individual sentiment data gave...
READ STORY

Learn more about how we can help

GET STARTED